O le a le uiga o le “manino”?
E le tauaveina e le manu le suiga. O le a le tupu ai le ma'i ma o le a lē tuʻuina atu.
Maile Achromatopsia Ituaiga 3 I le Siamani Fa'ailo Puupuu (PRAcd)
The DNA test for Achromatopsia Type 3 (PRAcd) in German Shorthaired Pointers is essential for responsible breeding. This genetic screening identifies carriers of the PRAcd mutation, which causes progressive vision loss and color blindness in affected dogs. Early detection through DNA testing helps breeders prevent passing this hereditary condition to future generations. By using the PRAcd test, owners can ensure healthier litters and maintain the breed’s overall well-being. Regular testing supports informed breeding decisions and promotes the longevity of German Shorthaired Pointers. Protect your dog’s vision and contribute to breed health with the Achromatopsia Type 3 DNA test.
Faapuupuuga: PRAcd
Su'ega su'esu'e: CNGB3 c.784G>A
Tofi: Autosomal Recessive
Acronym
PRAcd
Mata'ituina taimi
Fa'alema'i ogaoga
Fa'avasegaga fa'apitoa
Fa'ama'i Mata
Iloiloga suiga
CNGB3 c.784G>A
p.(D262N)
p.(D262N)
Faiga o tofi
Autosomal Recessive
Aotelega o su'ega:
The DNA test for Achromatopsia Type 3 (PRAcd) in German Shorthaired Pointers helps identify carriers and affected dogs. This inherited condition causes complete color blindness and vision problems. Early testing allows breeders to make informed decisions to reduce the risk of passing the disorder. By screening breeding dogs, the prevalence of PRAcd can be minimized in future generations. Responsible breeding ensures healthier dogs with better quality of life.
E maua mai le pusa: Basic
O lenei su'ega DNA e aofia ai e amata mai i le matou pusa Basic — ma o se vaega foi o pusa Basic, Standard, Advanced, Complete.
Va'ai DNA Su'ega Packs →Filifili le pusa e sili ona fetaui ma lau faʻatupuina poʻo le soifua maloloina o au manu.
Understanding Achromatopsia Type 3 in German Shorthaired Pointers
Achromatopsia Type 3, also known as Progressive Retinal Atrophy with complete color blindness (PRAcd), is a hereditary condition that affects the vision of German Shorthaired Pointers. This genetic disorder results from mutations in specific genes that are crucial for the proper functioning of photoreceptor cells in the retina, leading to vision impairment over time.
Symptoms of Achromatopsia Type 3
Dogs affected by Achromatopsia Type 3 typically exhibit symptoms such as a lack of color vision, difficulty seeing in bright light, and potential night blindness. Owners may notice that their dogs have trouble navigating their environment, particularly in brightly lit areas, as their ability to perceive colors is significantly diminished.
Genetic Basis of the Condition
This condition is inherited in an autosomal recessive manner, meaning that both copies of the gene must be mutated for the dog to express the disease. Carriers, which have one normal and one mutated gene, do not show symptoms but can pass the condition to their offspring. Identifying carriers through DNA testing is essential for responsible breeding practices, as it helps prevent the propagation of the condition in future generations.
Impact on Quality of Life
While Achromatopsia Type 3 can lead to significant visual impairment, many dogs adapt well to their condition. Owners can assist by providing a safe environment and ensuring that their pets are comfortable in low-light conditions or areas with bright lighting. Understanding the limitations of their dog's vision allows owners to make necessary adjustments to enhance their pet's quality of life.
Management and Care
Managing a dog with Achromatopsia Type 3 primarily involves environmental modifications rather than medical interventions. Owners should ensure that their living space is free from obstacles that could pose a danger, as affected dogs may not respond to visual cues in the same way as their sighted counterparts. Regular veterinary check-ups are also advised to monitor the dog's overall eye health and address any other potential issues that may arise.
Fa'ai'uga
Achromatopsia Type 3 in German Shorthaired Pointers is a serious genetic condition that affects visual perception. Understanding the symptoms, genetic basis, and management strategies is crucial for owners and breeders alike. Through responsible breeding and proper care, the impact of this condition on affected dogs can be alleviated, allowing them to lead fulfilling lives despite their visual challenges.
Fa'ailoga ua iloa mo le su'ega: Achromatopsia Ituaiga 3 I le Siamani Fa'ailo Puupuu (PRAcd)
- German Shorthaired Pointer
🧬 Interpretation of genotypes PRAcd
Genotype
Tulaga
🟡 N/N
E le fa'asalalau - Leai se lamatiaga
🟡 N/PRAcd
Avetaavale - Leai se lamatiaga
❌ PRAcd/PRAcd
A'afia - I Tulaga lamatia
FAQ: malamalama i le fa'amatalaga
E mata'utia ea se “Vaveina”?
Leai. E masani ona soifua maloloina le manu ae e mafai ona tuʻuina atu le suiga i lona fanau.
Ae faapefea pe a “Aafia” se manu?
E lua kopi suia. Fa'ailoga fa'afoma'i e fa'amoemoe e fa'atatau i le faama'i. E le tatau ona fafaga.
Aisea e iai le eseesega i le va o tane / fafine?
O nisi faʻamaʻi e fesoʻotaʻi feusuaʻiga, o lea e eseese ai o latou faʻaaliga e faʻatatau i le itupa a manu.
Va'ai le Fanau
N/N (le-faasalalau)
N/PRAcd (Va'ava'a)
PRAcd/PRAcd (A’afia)
Su'ega DNA FAQ
O le a le mea e iloa e lenei su'ega DNA?
This DNA test detects the mutation associated with Achromatopsia Type 3 In German Shorthaired Pointer (PRAcd) in order to identify clear, carrier, or at-risk animals.
Aisea e su'e ai se manu faifa'ato'aga?
O le su'ega DNA e fesoasoani i le au faifa'ato'aga e fuafua ni faigauo saogalemu ma fa'aitiitia ai le lamatiaga o le tu'uina atu o le suiga i fanau.
O le a le tulaga tofi o lenei suega?
Ole fa'asologa ole tofi na lipotia mo lenei su'ega ole Autosomal Recessive.
O le fea suiga o lo'o su'esu'eina i lenei su'ega?
This test analyses the mutation CNGB3 c.784G>A.
E a'afia se manu fe'avea'i?
E le faapea. O le fa'auigaina e fa'alagolago i le fa'asologa o tofi ma le fa'atupuina o le genotype.
Fa'asinomaga
Sidjanin Duska J, Lowe Jennifer K, McElwee John L, Milne Bruce S, Phippen Taryn M, Sargan David R, Aguirre Gustavo D, Acland Gregory M, Ostrander Elaine A. Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3. Hum Mol Genet. 2002 Aug 1;11(16):1823-33. doi: 10.1093/hmg/11.16.1823.